Pro Medicus Limited

ASX (AUD): Pro Medicus Limited (PME)

Last Price

278.67

Today's Change

-3.36 (1.19%)

Day's Change

276.86 - 283.56

Trading Volume

110,253

Overview

Market Cap

29 Billion

Shares Outstanding

104 Million

Avg Volume

293,534

Avg Price (50 Days)

230.72

Avg Price (200 Days)

225.79

PE Ratio

293.00

EPS

0.95

Earnings Announcement

12-Aug-2025

Previous Close

282.03

Open

283.34

Day's Range

276.86 - 283.56

Year Range

114.11 - 298.98

Trading Volume

110,416

Price Change Highlight

1 Day Change

-1.30%

5 Day Change

1.31%

1 Month Change

27.32%

3 Month Change

9.91%

6 Month Change

12.16%

Ytd Change

10.32%

1 Year Change

143.50%

3 Year Change

558.50%

5 Year Change

890.22%

10 Year Change

12108.33%

Max Change

24104.35%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Health Information Services

Description:

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment